Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-20

Clinical Trial Update: Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated red clover and lifestyle changes to alleviate menopausal symptoms in premenopausal breast cancer patients treated with tamoxi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Red Clover (Trifolium pratense)
  • Tamoxifen (tamoxifen)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED